Bottneuro develops Digital therapies for Alzheimer's Disease using Electrical stimulation of glia cells in the brain.
Bottneuro has raised $4.3M in total funding. The most recent round was Convertible Note. The last funding was announced in December 2022.
Bottneuro's investors include Venture Kick, Hemex, Zühlke Ventures AG, DART Ventures, IMD Startup Competition.
Bottneuro is headquartered in Basel, Switzerland.
Bottneuro develops Digital therapies for Alzheimer's Disease using Electrical stimulation of glia cells in the brain.
Bottneuro is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Bottneuro — Funding & Investors." VCBacked, December 15, 2022, https://www.vcbacked.co/company/bottneuro. Accessed November 12, 2026.
VCBacked. (2022). Bottneuro — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/bottneuro
{{cite web |title=Bottneuro — Funding & Investors |url=https://www.vcbacked.co/company/bottneuro |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Bottneuro? Request a listing update